Home / Market News / $EFX
benzinga Corporate Catalyst Impact 55/100 ● negative

Morgan Stanley Maintains Overweight on Equifax, Lowers Price Target to $205

Oct 13, 2026, 4:28 PM UTC · Primary ticker $EFX

Morgan Stanley analyst Toni Kaplan has reiterated an 'Overweight' rating on Equifax but reduced the price target from $225 to $205. This indicates a slightly less optimistic outlook on the stock's near-term valuation, though the overall positive sentiment remains.

Morgan Stanley's analyst Toni Kaplan maintained an 'Overweight' rating on Equifax, signaling continued confidence in the company's long-term prospects. However, the price target was lowered from $225 to $205, suggesting a recalibration of short-to-medium term valuation expectations. This adjustment could be due to various factors such as broader market conditions, revised growth projections for Equifax, or competitive pressures. For traders, this implies a potential slight downward pressure on EFX's stock price in the short term, as the lower price target might temper investor enthusiasm. Long-term investors might view this as a minor adjustment, given the maintained 'Overweight' rating, suggesting the core investment thesis remains intact.

$EFX negative Price target lowered
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.